BSE filing, NSE: PRUDENT. Summary written from the filing by ALFA Finder's alert engine.
Prudent Corporate Advisory Services Ltd: key numbers
- Share price
- ₹2,948.00
- Market cap
- ₹12,207 Cr
- Revenue (annual)
- ₹1,317 Cr
- Net profit (annual)
- ₹222.1 Cr
- P/E (TTM)
- 49.8×Sector 19.7×
- Promoter holding
- 55.31%+0.00% QoQ
- FII holding
- 14.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prudent Corporate Advisory Services Ltd
All →Prudent Corporate Advisory Services Capital Structure Change
Prudent Corporate Advisory will invest ₹6.53 Crore in a rights issue of its wholly owned subsidiary Prutech Financial Services. The funds support Prutech's planned portfolio management services expansion.
- Value
- ₹6.53 Cr
Prudent Corporate Advisory Services Results Update
Prudent's Q2 FY27 revenue grew 21.6% YoY to ₹388.7 Cr; PAT rose 33.9% to ₹71.7 Cr. Operating profit jumped 42.4% to ₹102.8 Cr on AUM growth.
Prudent Corporate Advisory Services Investor Presentation: Key Takeaways
Q2 FY27 deck: AUM ₹1,41,026 Cr, 21.6 lakh investors, 39,691 MFDs; equity AUM outgrowing industry (821 vs 589 rebased). No P&L disclosed.
Prudent Corporate Advisory Services Q2 FY27 Results: Net Profit ₹71.7 Cr, Up 34.0% YoY
Prudent Corporate Advisory Services Ltd reported revenue from operations of ₹388.7 Cr (+21.5% YoY) and net profit of ₹71.7 Cr (+34.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.7 Cr · +34.0% YoY
Prudent Corporate Advisory Services Board Meeting Date
Prudent Corporate Advisory schedules an October 28, 2026 board meeting for Q2 results and ESOP allotment. The trading window stays closed until 48 hours after results.
Prudent Corporate Advisory Services Other Announcement
Prudent Corporate Advisory Services Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI LODR Regulation 31(1)(b).
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date